Home, Personal Care and Performance Chemicals

Rossari Biotech reported record Q4 FY26 revenue of ₹684.9 crore, up 18.2% YoY, with PAT growing 33.7% to ₹46.0 crore. The company commissioned 15,000 MTPA ethoxylation capacity at Dahej, taking total